We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Histone Deacetylase May Be a Novel Therapeutic Strategy for Lung Cancer

News   Mar 27, 2020 | Original story from the Moffitt Cancer Center

 
Histone Deacetylase May Be a Novel Therapeutic Strategy for Lung Cancer

Credit: iStock

 
 
Advertisement
 

RELATED ARTICLES

Novel Pathology Could Improve Diagnosis and Treatment of Huntington’s Disease

News

Researchers have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington’s disease, and could be used to improve their diagnosis and treatment.

READ MORE

Atom-level Analysis of the NMDA Receptor Shows Neuronal Gatekeeper in Action

News

For the first time, researchers have been able to track each atom in the NMDA receptor, an important brain protein, as it transmits or inhibits neural signals.

READ MORE

Novel Vaccine Removes Aged Immune Cells in Mice

News

In a new study, researchers from Osaka University developed a novel vaccine that removes aged immune cells and then demonstrated an improvement of diabetes-associated metabolic derangements by vaccinating obese mice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE